(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 7.23% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.
Mckesson's revenue in 2025 is $344,583,000,000.On average, 7 Wall Street analysts forecast MCK's revenue for 2025 to be $45,196,782,465,145, with the lowest MCK revenue forecast at $44,682,098,997,138, and the highest MCK revenue forecast at $45,465,652,032,528. On average, 7 Wall Street analysts forecast MCK's revenue for 2026 to be $49,687,821,566,858, with the lowest MCK revenue forecast at $47,524,325,747,892, and the highest MCK revenue forecast at $51,285,758,803,418.
In 2027, MCK is forecast to generate $53,032,820,641,516 in revenue, with the lowest revenue forecast at $50,537,297,153,308 and the highest revenue forecast at $55,003,615,878,008.